The BCL6 and C-MYC cut-off values were carefully considered and adopted from previous studies 55,56 investigating the C-MYC, BCL2 and BCL6 expression in DLBCL patients. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.